Laboratory of Medicinal Chemistry, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium.
Bioorg Med Chem. 2012 Feb 15;20(4):1557-68. doi: 10.1016/j.bmc.2011.12.040. Epub 2011 Dec 27.
Recent drug discovery programs targeting urokinase plasminogen activator (uPA) have resulted in nonpeptidic inhibitors consisting of amidine or guanidine functional groups attached to aromatic or heteroaromatic scaffolds. There is a general problem of poor oral bioavailability of these charged inhibitors. In this paper, we report the synthesis and evaluation of a series of naphthamide and naphthalene sulfonamides as uPA inhibitors containing non-basic groups as substitute for amidine or guanidine groups.
近期针对尿激酶型纤溶酶原激活物(uPA)的药物研发项目已取得成果,开发出的非肽类抑制剂含有连接于芳基或杂芳基骨架的脒基或胍基官能团。这些带电荷抑制剂的口服生物利用度普遍较差。本文报道了一系列萘甲酰胺和萘磺酰胺作为 uPA 抑制剂的合成与评价,其中含有非碱性基团替代脒基或胍基。